与骨髓衰竭和血液恶性瘤相关的NHEJ1拼接变体
Nadav I Weinstock1, Carolyn Applegate1, Lei Peng2
1Department of Genetic Medicine, Johns Hopkins Hospital, Baltimore, Maryland, USA.
Pediatric blood & cancer
|June 28, 2025
概括
非同类末端结合 (NHEJ) 1 缺陷可能导致基因组维护障碍,严重的细胞衰竭和骨髓衰竭,而不仅仅是免疫缺陷. 早期诊断至关重要,因为NHEJ1在遗传组中经常被遗漏.
科学领域:
- 遗传学 是一个遗传学.
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
背景情况:
- 非同类末端结合 (NHEJ) 1 缺乏是已知的基因组维护障碍 (GMD) 的原因,通常表现为严重的综合免疫缺陷.
- 然而,临床表现的全谱,特别是除了淋巴细胞异常之外的血液学影响,仍然不完全理解.
研究的目的:
- 为了突出 NHEJ1 缺乏的未被认可的造血性影响.
- 强调在骨髓衰竭综合征的标准基因检测小组中,NHEJ1遗漏所带来的诊断挑战.
主要方法:
- 两名确诊患有NHEJ1缺乏症的患者的病例报告.
- 临床和诊断评估,包括遗传分析和血液学参数的随访.
主要成果:
- 一名患者出现了复发性细胞衰竭,演变为骨髓质疏松症,慢性骨髓单细胞白血病和急性骨髓性白血病.
- 第二名患者表现出细胞衰竭,但没有明显的免疫缺陷.
- 由于NHEJ1被排除在常见的遗传性骨髓衰竭综合征面板之外,这两种病例的诊断都被推迟了.
结论:
- 除了淋巴细胞缺陷之外,NHEJ1 缺陷表现出显著的造血异常,包括骨髓性恶性瘤.
- 需要将NHEJ1纳入遗传性骨髓衰竭综合征的遗传检测中,以确保及时诊断和管理.
- NHEJ1 缺陷有助于越来越多地了解结合骨髓和淋巴细胞问题的GMD.
相关概念视频
RNA Splicing
57.1K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
57.1K
Alternative RNA Splicing
21.7K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.7K
Regulation of Hematopoietic Stem Cells
3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
Multipotency of Hematopoietic Stem Cells
3.3K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.3K
Pre-mRNA Processing: RNA Splicing
5.4K
5.4K
Hematopoiesis
5.7K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.7K


